Form 4 for EW Edwards Lifesciences
Accepted 2022-04-29 00:00:00 ET · period of report 2022-04-29 · accession 0001225208-22-006312 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-29 | 2022-04-29 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $107.80 | -32.5K | 112.1K | -22% | -$3.51M |
| D | 2022-04-29 | 2022-04-29 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 79.3K | -14% | $0 |
| DI | 2022-04-29 | 2022-04-29 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.39M | +0.4% | $0 |
| D | 2022-04-29 | 2022-04-29 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 124.3K | +57% | +$980.3K |
| D | 2022-04-29 | 2022-04-29 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $0.00 | -45.0K | 45.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-29 | S | D | 8,934 | $105.81 | 103,198.82 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $105.390 to $106.380. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-04-29 | S | D | 11,427 | $109.12 | 91,771.82 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $108.500 to $109.500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-04-29 | G | D | 12,500 | $0.00 | 79,271.82 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-29 | G | A | 12,500 | $0.00 | 3,394,017 | I | — | — | |
| 5 | Common | Common Stock | 2022-04-29 | M | A | 45,050 | $21.76 | 124,321.82 | D By Living Trust | — | — | |
| 6 | Common | Common Stock | 2022-04-29 | S | D | 1,946 | $109.69 | 122,375.82 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $109.520 to $109.810. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2022-04-29 | S | D | 2,276 | $106.86 | 120,099.82 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $106.395 to $107.300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2022-04-29 | S | D | 7,967 | $107.94 | 112,132.82 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $107.410 to $108.395. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Derivative | Employee Stock Option (Right to Acquire) | 2022-04-29 | M | D | 45,050 | $0.00 | 45,050 | D | $21.76 · 2015-06-14 to 2022-05-13 | 45,050 Common Stock |